212, Novartis Investigational Site — Salt Lake City, Utah

212, Novartis Investigational Site is a clinical research site located in Salt Lake City, Utah, United States 84121.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

212, Novartis Investigational Site has participated in 1 clinical trials.

Therapeutic areas: Influenza Virus.

Sponsors: Seqirus.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Salt Lake City

Browse all research sites in Utah · View every site in Salt Lake City

• University of Utah Pediatric Emergency Medicine
• The Huntsman Cancer Institute, University of Utah Health Care
• University of Utah - Division of Infectious Diseases
• University of Utah, University Hospital
• Intermountain Health Care-LDS Hospital
• University of Utah /ID# 138250
• College of Health Research Complex--University of Utah
• University of Utah Cardiovascular Center
• Moran Eye Center, University of Utah
• University of Utah Sugarhouse Health Center
• PCH Pharmacy - Primary Children's Hospital - Pharmacy
• University of Utah, Clinical and Translational Sciences Institute

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 212, Novartis Investigational Site?

212, Novartis Investigational Site has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 212, Novartis Investigational Site conducted?

212, Novartis Investigational Site has 1 clinical trials on record. Their work covers Influenza Virus.

Is 212, Novartis Investigational Site accredited by Crixeo Clinical Trials?

212, Novartis Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 212, Novartis Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.